Arterys Cardio DL vs EchoSolv AS

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

Arterys Cardio DL

by Arterys (now part of Tempus)

EchoSolv AS

by Echo IQ

AI Verdict

While both are FDA-cleared, cloud-based AI tools in cardiology, their core functionalities diverge significantly. Arterys Cardio DL focuses on automating and enhancing cardiac MRI analysis through image segmentation and quantification, whereas EchoSolv AS provides clinical decision support for severe aortic stenosis by analyzing echocardiogram measurements. Therefore, they address different diagnostic modalities and specific clinical challenges within cardiology.

Choose Arterys Cardio DL if…

Choose Arterys Cardio DL if your primary need is advanced, automated analysis of cardiac MRI studies. This tool excels at providing rapid, editable ventricle segmentations, 4D Flow post-processing, and quantitative delayed enhancement analysis, significantly reducing interpretation time and enhancing diagnostic accuracy for comprehensive MRI assessments.

View Arterys Cardio DL →

Choose EchoSolv AS if…

Choose EchoSolv AS if you require an ultra-fast, measurement-based AI solution to identify patients at high risk for severe aortic stenosis from echocardiogram data. This platform provides accurate severe AS probability and guideline checks, acting as valuable clinical decision support and a second reader to help prioritize studies within existing workflows.

View EchoSolv AS →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	Arterys Cardio DL	EchoSolv AS
Deployment	Cloud-based (SaaS), integrates with existing PACS or EHR, web-based zero-footprint viewer (Mac, PC, tablet, phone). [4, 7, 9, 13, 27]	Cloud-based
FDA Status	1 AI-estimated	1 AI-estimated
HIPAA	Yes AI-estimated	Unknown

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	Arterys Cardio DL	EchoSolv AS
Name	Arterys Cardio DL	EchoSolv AS
Company	ARTERYS	Echo IQ
Description	FDA-cleared, cloud-based AI software that provides automated, editable ventricle segmentations for cardiac MRI analysis, drastically reducing interpretation time and enhancing diagnostic accuracy.	FDA-cleared, AI-powered clinical decision support platform by Echo IQ that analyzes echocardiograms to identify patients at risk for severe aortic stenosis with high accuracy and efficiency, integrating into existing workflows.
Primary Function	Automated, editable ventricle segmentations for cardiac MRI analysis	Analyzes echocardiograms to identify patients at risk for severe aortic stenosis
Key Differentiator	Deep learning algorithms for image analysis; 4D Flow post-processing	Measurement-based AI (analyzes numerical measurements, not images); Ultra-fast risk detection (under 3 seconds)
Specialties	Cardiology, Radiology	Cardiology, Cardiothoracic Surgery

Videos

Demos, reviews, and walkthroughs featuring Arterys Cardio DL and EchoSolv AS.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

What specific cardiac conditions or analyses do these tools address?

Arterys Cardio DL focuses on automated, editable ventricle segmentations for cardiac MRI analysis, including 4D Flow post-processing and Quantitative Delayed Enhancement analysis. EchoSolv AS is designed to identify patients at risk for severe aortic stenosis by analyzing echocardiograms.

Do these tools analyze medical images directly or numerical measurements?

Arterys Cardio DL utilizes deep learning algorithms for direct image analysis of cardiac MRIs to provide automated segmentations. In contrast, EchoSolv AS employs measurement-based AI, analyzing numerical echocardiogram measurements rather than the images themselves.

What kind of clinical insights or support do these tools provide?

Arterys Cardio DL provides automated ventricle segmentations, 4D Flow post-processing for blood flow visualization, and Quantitative Delayed Enhancement analysis from cardiac MRIs. EchoSolv AS offers severe aortic stenosis probability, a guideline check from measurements, and second reader support to help prioritize studies for closer review.

How do these tools integrate into existing clinical workflows?

Arterys Cardio DL is a cloud-based, vendor-agnostic platform for cardiac MRI analysis, designed for accessibility and performance. EchoSolv AS is designed to fit existing workflows, integrating with PACS and not requiring EMR integration, to provide clinical decision support.

What is the primary difference in their underlying AI methodology?

Arterys Cardio DL uses deep learning algorithms for direct image analysis of cardiac MRIs to generate segmentations. EchoSolv AS employs measurement-based AI that analyzes numerical measurements from echocardiograms to determine severe aortic stenosis probability.

How quickly do these tools deliver their results?

Arterys Cardio DL provides rapid analysis of cardiac MRIs in seconds, significantly reducing interpretation time from 30-60 minutes. EchoSolv AS offers ultra-fast risk detection for severe aortic stenosis in under 3 seconds.

More Comparisons

Assert-IQ vs Rapid Enterprise Platform

AISAP Cardio vs Rapid Enterprise Platform

AngioWaveNet vs Rapid Enterprise Platform

CorVista System with PH Add-On vs Rapid Enterprise Platform